Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luis Noel Winderling E Hijos
Original Assignee
Luis Noel Winderling E Hijos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luis Noel Winderling E HijosfiledCriticalLuis Noel Winderling E Hijos
Priority to ES221ApriorityCriticalpatent/ES221A1/es
Publication of ES221A1publicationCriticalpatent/ES221A1/es
ES221A1879-01-201879-01-20Fabricación de las piezas de prótesis dental empleando el aparato llamado "Prensa Dental o Inyector Winderling".
ExpiredES221A1
(es)
FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ÁCIDO (R-R*, R*)]-2-(4-FLUOROFENIL)-ß,o-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4-[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2 : 1) (ATORVASTATINA)
Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen
5,6,7-trihydroxyheptansäure und analoge zur behandlung von augenkrankheiten und mit hyperproliferativen und angiogenen reaktionen verbundenen krankheiten
Verwendung von 4-(4-chlorophenyl- sulphonylcarbamoyl) benzoyl - l - valyl - l - proline 1(rs) - (1-trifluoroacetyl-2- methylpropyl)amide zur herstellung eines medikaments für die behandlung von gefässkrankheiten